These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33966332)

  • 1. On-treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B.
    Peng CY; Chen CH
    Liver Int; 2021 Jul; 41(7):1700-1701. PubMed ID: 33966332
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
    Huang R; Zhang Z; Wang J; Zhang S; Wu C
    Aliment Pharmacol Ther; 2023 Nov; 58(9):965-966. PubMed ID: 37831536
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
    Zhao J
    Aliment Pharmacol Ther; 2023 Nov; 58(9):964. PubMed ID: 37831535
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early diagnosis and predictive model for hepatitis B virus-related hepatocellular carcinoma].
    Yang ST; Wang W; Wang YD; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):667-671. PubMed ID: 36038331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
    Wong GL
    J Gastroenterol Hepatol; 2012 Jan; 27(1):1-2. PubMed ID: 22188022
    [No Abstract]   [Full Text] [Related]  

  • 7. Occult hepatitis B virus infection: bit player or role player?
    Shire AM; Roberts LR
    Hepatology; 2011 Sep; 54(3):760-3. PubMed ID: 21735471
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview of HBV therapy.
    Pessoa MG; Wright TL
    Adv Exp Med Biol; 1999; 458():1-10. PubMed ID: 10549374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
    Warner N; Locarnini S
    Antivir Ther; 2009; 14(2):139-42. PubMed ID: 19430088
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations.
    Cargill Z; Brown SE; Dusheiko G; Agarwal K
    Gut; 2021 Mar; 70(3):629-630. PubMed ID: 32606207
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on: Expressions of MiR-132 in patients with chronic hepatitis B, posthepatitic cirrhosis and hepatitis B virus-related hepatocellular carcinoma.
    Santella B; Pignataro D; Lavano MA; Rinaldi M; Galdiero F
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1384-1385. PubMed ID: 30840257
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of chronic hepatitis B virus DNA negative transformation and HBsAg clearance on the occurrence of hepatocellular carcinoma].
    Zhou JL; Wang BQ; Shi YW; You H
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):831-833. PubMed ID: 31941236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma.
    Jin ZC; Chen JJ; Luo B; Zhang WH; Teng GJ
    Hepatology; 2023 Jan; 77(1):E5-E6. PubMed ID: 35839297
    [No Abstract]   [Full Text] [Related]  

  • 15. It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B.
    Jachs M; Tillmann HL
    Hepatology; 2023 Feb; 77(2):352-354. PubMed ID: 36114783
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Huang R; Wang J; Wu W; Yan X; Wu C
    Hepatology; 2020 Jun; 71(6):2173-2174. PubMed ID: 31858599
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncogenic viruses and hepatocellular carcinoma.
    Ben Ari Z; Weitzman E; Safran M
    Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.
    Lee HA; Seo YS; Kim SU
    Gastroenterology; 2020 Jun; 158(8):2310-2311. PubMed ID: 32201178
    [No Abstract]   [Full Text] [Related]  

  • 20. Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
    Jang BK
    Clin Mol Hepatol; 2016 Sep; 22(3):336-338. PubMed ID: 27729635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.